Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EAN 2017 | APOE haplotypes, ACE insertion/deletion polymorphism and neuropsychiatric symptoms in Alzheimer’s

Fabricio Ferreira De Oliveira • 24 Jun 2017
EAN 2017
Alzheimer’s Disease

Fabricio Ferreira De Oliveira, MD, PhD from the Federal University of São Paulo, São Paulo, Brazil gives an overview of a study on the APOE haplotypes and the angiotensin-converting enzyme (ACE) insertion/deletion polymorphism and their association with neuropsychiatric symptoms in Alzheimer’s disease.
Recorded at the 2017 Congress of the European Academy of Neurology (EAN) in Amsterdam, the Netherlands.

More from Fabricio Ferreira De Oliveira

Angiotensin receptor blockers on cognitive function in Alzheimer's disease
2:41
Angiotensin receptor blockers on cognitive function in Alzheimer's disease
Fabricio Ferreira De Oliveira • 24 Jun 2017
Motor aspects of daily living in patients with dementia with Lewy bodies and Parkinson's dementia
2:10
Motor aspects of daily living in patients with dementia with Lewy bodies and Parkinson's dementia
Fabricio Ferreira De Oliveira • 24 Jun 2017

Related Videos

A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
10:28
A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
Muhammad Umar Khan • 28 Aug 2026
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
3:25
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
Vikash Jaiswal • 26 Aug 2026
What are the biological mechanisms underlying the higher prevalence of AD in women?
1:55
What are the biological mechanisms underlying the higher prevalence of AD in women?
Amber Watts • 14 Jul 2026
MenoCog: risk and protective factors for cognitive function in the menopause transition
2:37
MenoCog: risk and protective factors for cognitive function in the menopause transition
Amber Watts • 14 Jul 2026

Choose your cookie settings

VJDementia uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJDementia is intended for healthcare professionals